Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LivaNova (LIVN) Operating Expenses (2016 - 2025)

Historic Operating Expenses for LivaNova (LIVN) over the last 12 years, with Q3 2025 value amounting to $187.1 million.

  • LivaNova's Operating Expenses rose 616.69% to $187.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $713.0 million, marking a year-over-year increase of 462.51%. This contributed to the annual value of $691.4 million for FY2024, which is 73.59% down from last year.
  • LivaNova's Operating Expenses amounted to $187.1 million in Q3 2025, which was up 616.69% from $185.0 million recorded in Q2 2025.
  • Over the past 5 years, LivaNova's Operating Expenses peaked at $187.1 million during Q3 2025, and registered a low of $150.4 million during Q3 2022.
  • Moreover, its 5-year median value for Operating Expenses was $169.9 million (2024), whereas its average is $169.1 million.
  • Per our database at Business Quant, LivaNova's Operating Expenses surged by 3490.92% in 2021 and then plummeted by 1402.93% in 2022.
  • Over the past 5 years, LivaNova's Operating Expenses (Quarter) stood at $168.5 million in 2021, then fell by 2.37% to $164.5 million in 2022, then decreased by 0.29% to $164.1 million in 2023, then increased by 6.02% to $173.9 million in 2024, then rose by 7.56% to $187.1 million in 2025.
  • Its Operating Expenses was $187.1 million in Q3 2025, compared to $185.0 million in Q2 2025 and $167.0 million in Q1 2025.